KAREN SMITH: Open Payments
NPI 1285186809 · SPRINGFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,028 in 53 payments from 20 companies in 2025. Trend: 2023 $3,764 · 2024 $4,047 · 2025 $2,028
Food & beverage: $2,028
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $323 |
| Gilead Sciences, Inc. | 2 | $237 |
| Neurocrine BioSciences, Inc. | 3 | $190 |
| Teva Pharmaceuticals USA, Inc. | 4 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $174 |
| GlaxoSmithKline, LLC. | 6 | $173 |
| Phathom Pharmaceuticals, Inc. | 3 | $119 |
| Cipher Pharmaceuticals US LLC | 1 | $99 |
| ABBVIE INC. | 4 | $90 |
| KYOWA KIRIN, INC. | 1 | $87 |
Products named: Wegovy, INGREZZA, CAPLYTA, AUSTEDO XR, Descovy, VOQUEZNA, Yeztugo, NUCALA.
Industry payments across PA — which companies pay providers there.
